Company: AIP
Filing Date: 2025-12-11
Form Type: S-3
Source: 0001193125-25-316098
Chunk: 48

Company: Arteris, Inc.
Filing Date: 2025-12-11
Form: S-3
Chunk 48
---
 substantial dilution in the net tangible book value per share of the common stock you purchase in this offering.

The price per share of our common stock being offered may be higher than the net tangible book value per share of our common stock
outstanding prior to this offering. Assuming that an aggregate of 3,824,579 shares are sold at a price of $19.61 per share, the last reported sale price of our common stock on the Nasdaq Global Market on December 10, 2025, for aggregate proceeds of
$75.0 million in this offering, and after deducting commissions and estimated aggregate offering expenses payable by us, you will suffer immediate and substantial dilution of $18.46 per share, representing the difference between the as adjusted net
tangible book value per share of our common stock as of September 30, 2025 after giving effect to this offering and the assumed offering price. See the section entitled “Dilution” below for a more detailed discussion of the dilution
you will incur if you purchase common stock in this offering.

You may experience future dilution as a result of future equity offerings.

In order to raise additional capital, we may in the future offer additional shares of our common stock or other securities
convertible into or exchangeable for our common stock. We cannot assure you that we will be able to sell shares or other securities in any other offering at a price per share that is equal to or greater than the price per share paid by investors in
this offering, and investors purchasing shares or other securities in the future could have rights superior to existing stockholders. The price per share at which we sell additional shares of our common stock or other securities convertible into or
exchangeable for our common stock in future transactions may be higher or lower than the price per share in this offering. As of September 30, 2025, approximately 12.7 million shares of common stock that are either subject to outstanding
options, reserved for future issuance under our equity incentive plans or subject to outstanding warrants are eligible for sale in the public market to the extent permitted by the provisions of various vesting schedules and Rule 144 and Rule 701
under the Securities Act.

S-6

The actual number of shares we will issue and gross proceeds resulting from those sales, at any one time or in total, is uncertain.

Subject to certain limitations in the sales agreement and compliance with applicable law, we have
the discretion to deliver a placement notice to Jefferies at any time